Cytotoxicity and mode of action of vanada- and niobatricarbadecaboranyl monohalide complexes in human HL-60 promyelocytic leukemia cells

Antiproliferative activity of (η6-arene)ruthenacarborane sandwich complexes against HCT116 and MCF7 cell lines

Three [(η⁶-arene)RuC₂B₉H₁₁] complexes (arene = p-cymene (2), biphenyl (3) and 1-Me-4-COOEt-C₆H₄ (4)) were synthesised according to modified literature procedures and fully characterised. 2-4 were found to be moderately active against two types of tumour cell lines (HCT116 and MCF7), with IC₅₀ values in the low micromolar range. However, viability of normal, healthy cells (MRC-5 cell line, MLEC and mouse macrophages) was not affected by treatment with 2-4, indicating high selectivity of the metallacarborane complexes towards tumour cell lines, compared to the unselective antitumour agent cisplatin and other potential Ru^II drugs. Moreover, flow cytometric analysis suggested that 4 induces cell death via a caspase-dependent apoptotic mechanism. DFT calculations of the frontier molecular orbitals showed that the HOMO-LUMO gap in 2-4 is smaller than in the corresponding cyclopentadienyl complexes 2-Cp-4-Cp (e.g. 5.47 (2) vs. 6.31 eV (2-Cp)). In order to assess the stability of 2-4, particularly the ruthenium-dicarbollide bond, energy decomposition analysis (EDA) of 2-4, together with the respective cyclopentadienyl analogues 2-Cp-4-Cp, was performed. EDA suggests that the ruthenium(ii)-dicarbollide bond in the three complexes is mostly ionic and far stronger than the ruthenium(ii)-arene bond.

Vanadium compounds in medicine

Vanadium is a transition metal that, being ubiquitously distributed in soil, crude oil, water and air, also found roles in biological systems and is an essential element in most living beings. There are also several groups of organisms which accumulate vanadium, employing it in their biological processes. Vanadium being a biological relevant element, it is not surprising that many vanadium based therapeutic drugs have been proposed for the treatment of several types of diseases. Namely, vanadium compounds, in particular organic derivatives, have been proposed for the treatment of diabetes, of cancer and of diseases caused by parasites. In this work we review the medicinal applications proposed for vanadium compounds with particular emphasis on the more recent publications. In cells, partly due to the similarity of vanadate and phosphate, vanadium compounds activate numerous signaling pathways and transcription factors; this by itself potentiates application of vanadium-based therapeutics. Nevertheless, this non-specific bio-activity may also introduce several deleterious side effects as in addition, due to Fenton's type reactions or of the reaction with atmospheric O2, VCs may also generate reactive oxygen species, thereby introducing oxidative stress with consequences presently not well evaluated, particularly for long-term administration of vanadium to humans. Notwithstanding, the potential of vanadium compounds to treat type 2 diabetes is still an open question and therapies using vanadium compounds for e.g. antitumor and anti-parasitic related diseases remain promising.

Syntheses and structural characterizations of inorganic ansa-metallocene analogues: ansa-ferratricarbadecaboranes

New linked cyclopentadienyl-tricarbadecaboranyl and bis-tricarbadecaboranyl dianions have been used to form the first examples of ansa-metallatricarbadecaboranyl complexes. The hybrid cyclopentadienyl-tricarbadecaboranyl dianion, Li2(+)[6-C5H4-(CH2)2-nido-5,6,9-C3B7H9](2-) (1), was produced by an initial carbon-insertion reaction of a nitrile-substituted cyclopentadiene with the arachno-4,6-C2B7H12(-) anion, followed by deprotonation to the dianion with LiH. The linked-cage bis-tricarbadecaboranyl dianion, Li2(+)[6,6'-(CH2)2-nido-(5,6,9-C3B7H9)2](2-) (2), was produced by a similar carbon-insertion route involving the reaction of two equivalents of arachno-4,6-C2B7H12(-) with succinonitrile. The reaction of 1 with an equivalent of FeCl2 produced the hybrid complex, ansa-(2-(CH2)2)-(1-η(5)-C5H4-closo-1,2,3,4-C3B7H9)Fe (3), with a crystallographic determination confirming the formation of a sandwich structure where the ring and cage are linked by the ansa -CH2CH2- group with attachment to the cage at the C2 carbon. The reaction of 2 with FeCl2 produced three isomeric ansa-(CH2)2-ferrabistricarbadecaboranyl sandwich complexes, ansa-(CH2)2-(closo-C3B7H9)2Fe (4, 5 and 6). Crystallographic determinations showed that in 4, the two tricarbadecaboranyl ligands are linked by the ansa-CH2CH2- group at the C2 and C2' cage carbons, whereas in 5 and 6 they are linked at their C2 and C4' carbons, with the structures of 5 and 6 differing in the relative positions of the C4' carbons in the two cages of each complex. The structural determinations also showed that, depending upon the linking position of the ansa-tether, constraints in cage-orientation, such as observed in 4, produce unfavorable intercage steric interactions. However, the cage fragments in these complexes can readily undergo a cage-carbon migration that moves one -carbon and its tether linkage to the more favorable 4-position. This isomerization reduces the cage steric interactions and produces configurations, such as those found for 5 and 6, where the iron cage bonding is enhanced as a result of the binding effect of the tether.

New palladium-catalyzed cross-coupling routes to carbon functionalized metallatricarbadecaboranes

A general method for the synthesis of cage-carbon-functionalized cyclopentadienyl iron and cyclopentadienyl ruthenium tricarbadecaboranyl complexes has been developed that employs palladium-catalyzed Sonogashira, Heck, and Stille cross-coupling reactions directed at a cage-carbon haloaryl substituent. The key Li(+)[6-(p-XC(6)H(4))-nido-5,6,9-C(3)B(7)H(9)(-)] (X = I (1), Br (2), Cl (3)) haloaryl-tricarbadecaboranyl anionic ligands were synthesized in high yields via the reaction of the arachno-4,6-C(2)B(7)H(12)(-) anion with the corresponding p-halobenzonitriles (p-XC(6)H(4)-CN). The reactions of the salts 1-3 with (η(5)-C(5)H(5))Fe(CO)(2)I and (η(5)-C(5)H(5))Ru(CH(3)CN)(3)PF(6) were then used to produce the haloaryl complexes 1-(η(5)-C(5)H(5))-2-(p-XC(6)H(4))-closo-1,2,3,4-MC(3)B(7)H(9) (M = Fe, X = I (4), Br (5), Cl (6) and M = Ru, X = I (7), Br (8), Cl (9)). The sonication-promoted Sonogashira coupling reactions of 4 with terminal alkynes catalyzed by Pd(dppf)(2)Cl(2)/CuI yielded the alkynyl-linked derivatives 1-(η(5)-C(5)H(5))-2-p-RC(6)H(4)-closo-1,2,3,4-FeC(3)B(7)H(9) (R = (PhC≡C)- (10), (CH(3)CH(2)C(O)OCH(2)C≡C)- (11), ((η(5)-C(5)H(5))Fe(η(5)-C(5)H(4)C≡C))- (12)). Heck reactions of 4 with terminal alkenes catalyzed by Pd(OAc)(2) yielded the alkene-functionalized products 1-(η(5)-C(5)H(5))-2-p-RC(6)H(4)-closo-1,2,3,4-FeC(3)B(7)H(9) (R = (PhCH(2)CH═CH)- (13), (CH(3)(CH(2))(2)CH═CH)- (14)), while the Stille cross-coupling reactions of 4 with organotin compounds catalyzed by Pd(PPh(3))(2)Cl(2) afforded the complexes 1-(η(5)-C(5)H(5))-2-p-RC(6)H(4)-closo-1,2,3,4-FeC(3)B(7)H(9) (R = Ph- (15), (CH(2)═CH)- (16), (CH(2)═CHCH(2))- (17)). These reactions thus provide facile and systematic access to a wide variety of new types of functionalized metallatricarbadecaboranyl complexes with substituents needed for potential metallocene-like biomedical and/or optoelectronic applications.